This paper is in the following e-collection/theme issue:

mHealth for Symptom and Disease Monitoring, Chronic Disease Management (1034) Artificial Intelligence (669) New Methods (667) Machine Learning (1009) Digital Biomarkers and Digital Phenotyping (138) Diagnostic Tools in Mental Health (172)

Published on in Vol 8 , No 8 (2020) :August

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/19962, first published .
Predicting Early Warning Signs of Psychotic Relapse From Passive Sensing Data: An Approach Using Encoder-Decoder Neural Networks

Predicting Early Warning Signs of Psychotic Relapse From Passive Sensing Data: An Approach Using Encoder-Decoder Neural Networks

Predicting Early Warning Signs of Psychotic Relapse From Passive Sensing Data: An Approach Using Encoder-Decoder Neural Networks

Authors of this article:

Daniel A Adler 1 Author Orcid Image ;   Dror Ben-Zeev 2 Author Orcid Image ;   Vincent W-S Tseng 1 Author Orcid Image ;   John M Kane 3 Author Orcid Image ;   Rachel Brian 2 Author Orcid Image ;   Andrew T Campbell 4 Author Orcid Image ;   Marta Hauser 5 Author Orcid Image ;   Emily A Scherer 6 Author Orcid Image ;   Tanzeem Choudhury 1 Author Orcid Image
Article Authors Cited by (28) Tweetations (12) Metrics

Journals

  1. Henson P, D’Mello R, Vaidyam A, Keshavan M, Torous J. Anomaly detection to predict relapse risk in schizophrenia. Translational Psychiatry 2021;11(1) View
  2. Asuzu K, Rosenthal M. Mobile device use among inpatients on a psychiatric unit: A preliminary study. Psychiatry Research 2021;297:113720 View
  3. Gutierrez L, Rabbani K, Ajayi O, Gebresilassie S, Rafferty J, Castro L, Banos O. Internet of Things for Mental Health: Open Issues in Data Acquisition, Self-Organization, Service Level Agreement, and Identity Management. International Journal of Environmental Research and Public Health 2021;18(3):1327 View
  4. Koyama T, Sato S, Toriumi M, Watanabe T, Nimura A, Okawa A, Sugiura Y, Fujita K. A Screening Method Using Anomaly Detection on a Smartphone for Patients With Carpal Tunnel Syndrome: Diagnostic Case-Control Study. JMIR mHealth and uHealth 2021;9(3):e26320 View
  5. Cook D, Schmitter-Edgecombe M. Fusing Ambient and Mobile Sensor Features Into a Behaviorome for Predicting Clinical Health Scores. IEEE Access 2021;9:65033 View
  6. Steingrímsson S, Odéus E, Cederlund M, Franzén S, Helgesson C, Nyström K, Sondell J, Opheim A. Weighted blanket and sleep medication use among adults with psychiatric diagnosis – a population-based register study. Nordic Journal of Psychiatry 2022;76(1):29 View
  7. Tønning M, Faurholt-Jepsen M, Frost M, Bardram J, Kessing L. Mood and Activity Measured Using Smartphones in Unipolar Depressive Disorder. Frontiers in Psychiatry 2021;12 View
  8. Frank E, Wallace M, Matthews M, Kendrick J, Leach J, Moore T, Aranovich G, Choudhury T, Shah N, Framroze Z, Posey G, Burgess S, Kupfer D. Personalized digital intervention for depression based on social rhythm principles adds significantly to outpatient treatment. Frontiers in Digital Health 2022;4 View
  9. Adler D, Wang F, Mohr D, Choudhury T, Chen C. Machine learning for passive mental health symptom prediction: Generalization across different longitudinal mobile sensing studies. PLOS ONE 2022;17(4):e0266516 View
  10. Zhou J, Lamichhane B, Ben-Zeev D, Campbell A, Sano A. Predicting Psychotic Relapse in Schizophrenia With Mobile Sensor Data: Routine Cluster Analysis. JMIR mHealth and uHealth 2022;10(4):e31006 View
  11. Lakhtakia T, Bondre A, Chand P, Chaturvedi N, Choudhary S, Currey D, Dutt S, Khan A, Kumar M, Gupta S, Nagendra S, Reddy P, Rozatkar A, Scheuer L, Sen Y, Shrivastava R, Singh R, Thirthalli J, Tugnawat D, Bhan A, Naslund J, Patel V, Keshavan M, Mehta U, Torous J. Smartphone digital phenotyping, surveys, and cognitive assessments for global mental health: Initial data and clinical correlations from an international first episode psychosis study. DIGITAL HEALTH 2022;8:205520762211337 View
  12. Moura I, Teles A, Viana D, Marques J, Coutinho L, Silva F. Digital Phenotyping of Mental Health using multimodal sensing of multiple situations of interest: A Systematic Literature Review. Journal of Biomedical Informatics 2023;138:104278 View
  13. Kwon S, Firth J, Joshi D, Torous J. Accessibility and availability of smartphone apps for schizophrenia. Schizophrenia 2022;8(1) View
  14. Pap I, Oniga S. A Review of Converging Technologies in eHealth Pertaining to Artificial Intelligence. International Journal of Environmental Research and Public Health 2022;19(18):11413 View
  15. Lee D, Kim C, Lee S, Son S, Cho S, Cho Y, Lim J, Park R. Psychosis Relapse Prediction Leveraging Electronic Health Records Data and Natural Language Processing Enrichment Methods. Frontiers in Psychiatry 2022;13 View
  16. Cochran J, Fang H, Le Gallo C, Peters-Strickland T, Lindenmayer J, Reuteman-Fowler J. Participant Engagement and Symptom Improvement: Aripiprazole Tablets with Sensor for the Treatment of Schizophrenia. Patient Preference and Adherence 2022;Volume 16:1805 View
  17. Zlatintsi A, Filntisis P, Garoufis C, Efthymiou N, Maragos P, Menychtas A, Maglogiannis I, Tsanakas P, Sounapoglou T, Kalisperakis E, Karantinos T, Lazaridi M, Garyfalli V, Mantas A, Mantonakis L, Smyrnis N. E-Prevention: Advanced Support System for Monitoring and Relapse Prevention in Patients with Psychotic Disorders Analyzing Long-Term Multimodal Data from Wearables and Video Captures. Sensors 2022;22(19):7544 View
  18. Carlier C, Niemeijer K, Mestdagh M, Bauwens M, Vanbrabant P, Geurts L, van Waterschoot T, Kuppens P. In Search of State and Trait Emotion Markers in Mobile-Sensed Language: Field Study. JMIR Mental Health 2022;9(2):e31724 View
  19. Miller M, Raugh I, Strauss G, Harvey P. Remote digital phenotyping in serious mental illness: Focus on negative symptoms, mood symptoms, and self-awareness. Biomarkers in Neuropsychiatry 2022;6:100047 View
  20. Harvey P, Depp C, Rizzo A, Strauss G, Spelber D, Carpenter L, Kalin N, Krystal J, McDonald W, Nemeroff C, Rodriguez C, Widge A, Torous J. Technology and Mental Health: State of the Art for Assessment and Treatment. American Journal of Psychiatry 2022;179(12):897 View
  21. Torous J, Bucci S, Bell I, Kessing L, Faurholt‐Jepsen M, Whelan P, Carvalho A, Keshavan M, Linardon J, Firth J. The growing field of digital psychiatry: current evidence and the future of apps, social media, chatbots, and virtual reality. World Psychiatry 2021;20(3):318 View
  22. Gumley A, Bradstreet S, Ainsworth J, Allan S, Alvarez-Jimenez M, Aucott L, Birchwood M, Briggs A, Bucci S, Cotton S, Engel L, French P, Lederman R, Lewis S, Machin M, MacLennan G, McLeod H, McMeekin N, Mihalopoulos C, Morton E, Norrie J, Schwannauer M, Singh S, Sundram S, Thompson A, Williams C, Yung A, Farhall J, Gleeson J. The EMPOWER blended digital intervention for relapse prevention in schizophrenia: a feasibility cluster randomised controlled trial in Scotland and Australia. The Lancet Psychiatry 2022;9(6):477 View
  23. Coutts F, Koutsouleris N, McGuire P. Psychotic disorders as a framework for precision psychiatry. Nature Reviews Neurology 2023 View
  24. Yang Y, Xu F, Chen J, Tao C, Li Y, Chen Q, Tang S, Lee H, Shen W. Artificial intelligence-assisted smartphone-based sensing for bioanalytical applications: A review. Biosensors and Bioelectronics 2023;229:115233 View

Books/Policy Documents

  1. Schneider H. Artificial Intelligence in Medicine. View
  2. Schneider H. Artificial Intelligence in Medicine. View
  3. Opoku Asare K, Visuri A, Vega J, Ferreira D. Wireless Mobile Communication and Healthcare. View